Joseph L. Goldstein, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 2,000 shares at $360.00 ($710K) on 2019-11-22, disclosed to the SEC on 2019-11-22.
Open-market sale of $710k REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $350.00 | 1,000 | $350K | 49.3% |
| 2 | $360.00 | 1,000 | $360K | 50.7% |
| Total | $355.00 avg | 2,000 | $710K | 100% |
| Filing → |
| REGN | SELL | 2022-04-01 | $1.7M | — | Filing → |
| REGN | SELL | 2021-09-13 | $1.6M | — | Filing → |
| REGN | SELL | 2021-06-08 | $1.0M | — | Filing → |